Attention and Eye Movement in Parkinson's Disease and Other Movement Disorders

This study is looking at how deep brain stimulation (DBS) affects attention, how your eyes move, and how you understand social cues in people with Parkinson's disease (PD), essential tremor (ET), and dystonia (DT). Researchers want to see if problems with attention and eye movement in PD change how people interpret social cues, and if DBS can improve or worsen these issues. They are also exploring if DBS settings can be adjusted to help with attention while still treating other symptoms. You might receive your usual DBS settings, or DBS with reduced current or reduced frequency. The study will measure facial expression ratings, eye movements, and brain activity during surgery. This study is for people aged 19 to 90 who have been diagnosed with PD, ET, or DT and are able to give informed consent and make perceptual judgments. The current status of this study is unclear, and it plans to enroll 138 participants.

Study design
This is an interventional study, meaning participants will receive specific treatments. It plans to enroll 138 participants.
What's involved
You will have measurements taken at baseline (before DBS implantation), during the DBS surgery, and 2-3 weeks after surgery once your stimulation is optimized.
Compensation
Not stated in the trial record.
Follow-up
You will be followed for 2-3 weeks after DBS implantation for post-operative measurements.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06899022

Attention and Eye Movement in Parkinson's Disease

Recruiting
NAAges 19–90InterventionalBasic science
University of Nebraska
~138 participants
Updated 2026-05-05 on ClinicalTrials.gov
What's tested:Normal therapeutic DBSReduced current DBSReduced frequency DBS

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Facial Expression Rating
Measured over Baseline (within 2 weeks pre-DBS implantation), intraoperative (Day 0; day of DBS implantation surgery, and post-operative follow-up (2-3 weeks after DBS implantation, following clinical optimization of stimulation parameters).
+2 more outcomes measured
Essential Tremor
Parkinson's Disease (PD)
Dystonias
1 sites across 1 states
Nebraska1
  • Christopher K Kovach, PhD · PRINCIPAL_INVESTIGATOR · University of Nebraska

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

All Participants (Aim 1):
Ability and willingness to provide signed informed consent for this study
Ability to express perceptual judgments through a button press or mouse- controlled computerized slider
Age 19 - 90 years
DBS Participants (Aim 1):
Diagnosis of idiopathic Parkinson's disease (PD), essential tremor (ET) or dystonia (DT).
Scheduled for new implantation of a therapeutic DBS device targeted to subthalamic nucleus (STN), ventral intermediate nucleus of thalamus (VIM) or internal globus pallidus (GPi)
Comparison Participants (Aim 1):
Parkinson's disease (PD), essential tremor (ET) and dystonia (DT) Participants (Aim 2):
Ability and willingness to provide signed informed consent for this study
Ability to express perceptual judgments through a button press or mouse- controlled computerized slider
Age 19 - 90 years
Scheduled for awake DBS implantation with clinical micro-electrode recordings (MER)
Willing and able to engage in tasks during an awake surgical procedure
Parkinson's disease (PD), essential tremor (ET) and dystonia (DT) Participants (Aim 3):
Ability and willingness to provide signed informed consent for this study
Ability to express perceptual judgments through a button press or mouse- controlled computerized slider
Age 19 - 90 years
Willing to undergo acute manipulations of DBS
Able to tolerate acute changes of DBS

Exclusion

All Participants (Aim 1):
Corrected visual acuity insufficient to perceptually judge face stimuli
Inability to understand task instructions or complete task requirements
DBS Participants (Aim 1):
Healthy Comparison Participants (Aim 1):
Parkinson's disease (PD), essential tremor (ET) and dystonia (DT) Participants (Aim 2):
Corrected visual acuity insufficient to perceptually judge face stimuli
Inability to understand task instructions or complete task requirements
Not undergoing awake DBS implantation
Uncorrected visual acuity insufficient to perceptually judge face stimuli
Parkinson's disease (PD), essential tremor (ET) and dystonia (DT) Participants (Aim 3):
Corrected visual acuity insufficient to perceptually judge face stimuli
Inability to understand task instructions or complete task requirements
Failure of DBS to achieve a therapeutic effect on motor symptoms
  • Facial Expression RatingBaseline (within 2 weeks pre-DBS implantation), intraoperative (Day 0; day of DBS implantation surgery, and post-operative follow-up (2-3 weeks after DBS implantation, following clinical optimization of stimulation parameters).

    Participants will rate facial expression along a continuous scale using a computerized slider, following the affective bias task (ABT) of Bijanki et al. (2014). The scale is anchored with three descriptors, "Very Sad" at slider value 0 (left), "Neutral", at position 0.5 (middle), and "Very Happy" at 1.0 (right). Responses are compared between two time points: (1) at the initial pre-surgical testing session and post DBS implantation and (2) at the post-implantation session following clinical optimization of therapeutic parameters, 2-3 weeks after surgery. The comparison will examine both the direction of any bias of the rating, against normative ratings, and the magnitude of average deviation from normative ratings. Finally, the ratings will be incorporated into a generalized linear model of gaze position (Kovach 2014) to identify the association between perceived facial expression and characteristic fixation patterns.

  • Eye TrackingBaseline (within 2 weeks pre-DBS implantation), intraoperative (Day 0; day of DBS implantation surgery, and post-operative follow-up (2-3 weeks after DBS implantation, following clinical optimization of stimulation parameters).

    The location and duration of gaze fixations will be recorded with a remote eye tracking camera. The location of gaze fixations will be treated as the dependent measure within a generalized linear modeling (GLM) framework for spatial point processes, described in Kovach and Adolphs (2014). Parameter estimates of the model give the log relative risk of fixation at different locations in the visual scene as a function of the independent measures of the model. Independent measures include the main effect of (1) Fourier basis functions encoding scene location and its interactions with (2) image rating in the affective bias task of Bijanki et. al (2014), (3) session and (4) DBS stimulation state. Measures derived from the GLM model will also include the statistical deviation (e.g. Kullback-Leibler divergence) from the average distribution of fixations observed in healthy comparison subjects for each image.

  • Intraoperative MicrorecordingsIntraoperative (Day 0; day of DBS implantation surgery).

    During the Aim 2 portion of the study, patients undergoing awake DBS surgery as part of standard clinical care will engage in a subset of the face rating tasks during the surgery. Invasive recordings will be obtained from DBS target structures, including STN, VIM, and GPi using microelectrodes that are placed as part of standard clinical practice. Spike sorting will be used to identify firing of individual cells and firing rate will compared to eye movements to identify responses associated with shifts of attention in the targeted deep brain structures . These measures will be compared across movement-disorders populations using mixed-effects linear modeling and other standard statistical procedures.